Xylyx Bio, Inc. Employee Directory
Biotechnology ResearchNew York, United States11-50 Employees
Xylyx Bio, Inc. is a biotechnology research company based in Brooklyn, New York. It aims to bioengineer human whole organ grafts for life-saving transplantation, with the goal of reducing transplant waiting list mortality and healthcare costs. In May 2024, the company announced an exclusive license with Vanderbilt University for a xenogeneic cross-circulation platform designed to restore damaged donor organs to transplant-ready condition. Operating in the regenerative medicine field, Xylyx Bio focuses on technologies for organ and tissue repair. Its work serves researchers and clinical partners involved in transplantation and regenerative therapies, seeking to increase the availability of transplantable organs. As a Brooklyn-based biotechnology firm with a focused scope, it occupies a specialized niche within the broader biotech landscape.